BEVERLY HILLS, CA, May 08, 2011 (Press-News.org) The Hand and Wrist Institute, the leading hand specialist experts in the State of California now offers a "Where Does It Hurt" tool on their website, www.handandwristinstitute.com.
The Hand and Wrist Institute is a medical center that focuses primarily on the surgery of hands and wrists. This institute is backed by Dr. John T. Knight, one of the top medical experts in the field of hand and wrist surgery. Dr. John T. Knight is a board certified Orthopedic Surgeon who oversees the operations of the Hand and Wrist Institute at DISC to ensure that all of their patients get only the best of the best medical attention. Dr. Knight's medical expertise is reflected on the type of service they offer at the said institute because they not only hire the best medical experts in the field of hands and wrists but also have the most up to date procedures and the most technologically advanced equipment like Carpal Tunnel Release Los Angeles and Tennis Elbow Doctor Los Angeles.
Because of the combination of great procedures, a competent staff, and reliable equipment, the services offered by the Hand and Wrist Institute at DISC seems to be some of the best in the field as well. Like most hand specialists, the people behind the Hand and Wrist Institute and LA Hand Surgery perform surgeries that treat their patients. Unlike most surgeons, however, the people from the Hand and Wrist Institute go the extra mile. For example, instead of simply giving back mobility to a patient's hands or wrist, the experts at the Hand and Wrist Institute give back full mobility to the hands and wrists. And although this does not seem to make much of a difference, the fact that their patients can use their hands exactly like they used to before the injury is something that may not betaken for granted.
Because of all these little details that may spell all the difference for a patient, the Hand and wrist Institute deemed it important to actually have some relevant information on their online site. This is why www.handandwristinstitute.com is such a comprehensive and easy to use (and navigate within and around) website. This is specifically designed for online visitors who may want to learn something about a particular injury. But how about for a person who seems to experience some discomfort or pain but has no idea on what the problem might be?
For that, the Hand and Wrist Institute specifically created a part in their website called "Where Does It Hurt". This interactive tool is specifically designed to help people find out what possible conditions they could be suffering from. All the website visitor has to do is to check out the visual representation of the human body and then pinpoint which parts (of their body) actually hurt. Then, the website tells the website visitor about the possible disorders or diseases they may be suffering from; and then gives them proper information about such.
If you want to try out the "Where Does It Hurt" section of the website, you may visit http://www.handandwristinstitute.com. For comments, suggestions, or appointment, you may contact them through (310) 6843989, (949) 2886622, or the toll-free number 888-HAND-074.
Dr. Knight Offers Interactive Where Does it Hurt Online Tool
The Hand and Wrist Institute, the leading hand specialist experts in the State of California now offers a "Where Does It Hurt" tool on their website, www.handandwristinstitute.com.
2011-05-08
ELSE PRESS RELEASES FROM THIS DATE:
New technology helps to find gene responsible for Kufs disease
2011-05-08
Scientists from the Walter and Eliza Hall Institute and the University of Melbourne have used innovative new technologies to identify the gene responsible for a rare but fatal hereditary brain disorder. The discovery will make it possible to diagnose the disease through a blood test rather than a brain biopsy.
Dr Melanie Bahlo, Ms Katherine Smith and Ms Catherine Bromhead from the Walter and Eliza Hall Institute's Bioinformatics division, in collaboration with neurologist and epilepsy specialist Professor Sam Berkovic and Dr Todor Arsov from the University of Melbourne, ...
PCH Treatment Treats Panic Disorder
2011-05-08
The Psychological Care and Healing Treatment Center, the leading destination for people who want to have their psychological disorders fixed, now offers Panic Disorder treatment Clinic.
A Panic Disorder is considered as such when a person experiences several panic attacks within a short period of time. First of all, people must know that panic attacks are not very common. In fact, some people live their lives and experience only as little as two or three panic attacks through out their lives. This is why it is very uncommon to experience or suffer from several panic ...
Strong evidence supports prognostic value of circulating tumor cells in breast cancer
2011-05-08
French researchers have reported the strongest proof yet that evidence of 'circulating tumor cells' found in samples of a patient's blood is strongly linked to poor outcomes such as a short time to disease progression.
At the IMPAKT Breast Cancer Conference in Brussels, Dr François-Clement Bidard and colleagues from Institut Curie in Paris say their new findings set the scene for interventional trials designed to see if improved outcomes can be achieved by modifying treatment based on circulating tumor cell counts.
"We needed to do this study to confirm data provided ...
Epigenetic study reveals new insights into breast cancer
2011-05-08
The most comprehensive analysis yet of the epigenetic modifications present in breast cancer has revealed potentially important new ways to detect and treat the disease, Belgian researchers have reported.
Epigenetics is a term used to describe modifications to the DNA molecule that affect way its code is translated into proteins. These changes include methylation, a form of chemical modification.
Although researchers knew epigenetics was important in cancer, information about its exact contribution to breast carcinogenesis was scant, Dr Sarah Dedeurwaerder, from Université ...
Gene expression predicts chemotherapy sensitivity of triple-negative breast cancer
2011-05-08
German researchers have identified an unexpected molecular marker that predicts how sensitive hard-to-treat triple-negative breast cancers are to chemotherapy.
Triple-negative breast cancers --which do not express the genes for estrogen receptor, or progesterone receptor and do not have Her2/neu overexpression or amplification-- are more aggressive than other forms of the disease and cannot be treated with endocrine or Her2 targeted therapies.
At the IMPAKT Breast Cancer Conference in Brussels, PhD student Carolin Huelsewig and Dr Cornelia Liedtke from Uniklinikum Muenster ...
Breast cancer multi-gene tests compared
2011-05-08
Two multi-gene tests designed to predict the risk of disease progression and response to chemotherapy in breast cancer produce broadly similar results for high- and low-risk patients, but do not always agree in their predictions for those at intermediate risk, a new analysis shows.
In recent years, several genomic tests have been developed to provide prognostic information for breast cancer. Dr Catherine Kelly from Mater Misericordiae University Hospital, Dublin, Ireland, and colleagues in the USA examined the agreement in prediction results between two multi-gene assays ...
Protein snapshots reveal clues to breast cancer outcomes
2011-05-08
Measuring the transfer of tiny amounts of energy from one protein to another on breast cancer cells has given scientists a detailed view of molecular interactions that could help predict how breast cancer patients will respond to particular therapies.
At the IMPAKT Breast Cancer Conference in Brussels, Dr Gargi Patel from the Richard Dimbleby Department, King's College London, described cutting-edge research in which she and colleagues captured detailed information about protein interactions on cancer cells, and correlated that with established genetic markers for cancer ...
Anti-inflammatory drug may fight breast cancer
2011-05-08
The anti-inflammatory drug celecoxib may be a useful additional treatment for people with breast cancer, Dutch researchers report at the IMPAKT Breast Cancer Conference in Brussels.
The results of a randomized trial in 45 patients with primary invasive breast cancer showed that the drug --which is currently used to treat arthritis and other painful conditions-- clearly induced an anti-tumor response at the molecular level.
"This is exciting because it means that a medication already used to treat other diseases may be efficient in the adjuvant treatment of breast cancer ...
Female-to-male transsexual people have more autistic traits
2011-05-08
Domenico Di Ceglie, Director of Training and Research at the Gender Identity Development Service at the Tavistock and Portman NHS Foundation Trust in London, commented: "These are important findings in the field of gender incongruence, which need to be replicated. The awareness of the presence of autistic features may help these young people to explore the reasons behind their perceptions, and help them make more informed decisions about treatment."
Emma Martin, who runs a Gender Identity Support and research group in Little Downham, UK, welcomed the new findings, and ...
New biosensor modelled on the immune system can detect, track and guide the clean-up of oil spills
2011-05-08
A new biosensor which uses antibody-based technology has been shown to detect marine pollutants such as oil cheaper and faster than current technology. Tests of the new biosensor, published in Environmental Toxicology and Chemistry, reveal how it could be used for the early detection and tracking of oil spills.
The biosensor has been developed by researchers at the Virginia Institute of Marine Science (VIMS) and was tested in the Elizabeth River and Yorktown Creek which both drain into Virginia's Chesapeake Bay.
"Our biosensor combines the power of the immune system ...
LAST 30 PRESS RELEASES:
Twelve questions to ask your doctor for better brain health in the new year
Microelectronics Science Research Centers to lead charge on next-generation designs and prototypes
Study identifies genetic cause for yellow nail syndrome
New drug to prevent migraine may start working right away
Good news for people with MS: COVID-19 infection not tied to worsening symptoms
Department of Energy announces $179 million for Microelectronics Science Research Centers
Human-related activities continue to threaten global climate and productivity
Public shows greater acceptance of RSV vaccine as vaccine hesitancy appears to have plateaued
Unraveling the power and influence of language
Gene editing tool reduces Alzheimer’s plaque precursor in mice
TNF inhibitors prevent complications in kids with Crohn's disease, recommended as first-line therapies
Twisted Edison: Bright, elliptically polarized incandescent light
Structural cell protein also directly regulates gene transcription
Breaking boundaries: Researchers isolate quantum coherence in classical light systems
Brain map clarifies neuronal connectivity behind motor function
Researchers find compromised indoor air in homes following Marshall Fire
Months after Colorado's Marshall Fire, residents of surviving homes reported health symptoms, poor air quality
Identification of chemical constituents and blood-absorbed components of Shenqi Fuzheng extract based on UPLC-triple-TOF/MS technology
'Glass fences' hinder Japanese female faculty in international research, study finds
Vector winds forecast by numerical weather prediction models still in need of optimization
New research identifies key cellular mechanism driving Alzheimer’s disease
Trends in buprenorphine dispensing among adolescents and young adults in the US
Emergency department physicians vary widely in their likelihood of hospitalizing a patient, even within the same facility
Firearm and motor vehicle pediatric deaths— intersections of age, sex, race, and ethnicity
Association of state cannabis legalization with cannabis use disorder and cannabis poisoning
Gestational hypertension, preeclampsia, and eclampsia and future neurological disorders
Adoption of “hospital-at-home” programs remains concentrated among larger, urban, not-for-profit and academic hospitals
Unlocking the mysteries of the human gut
High-quality nanodiamonds for bioimaging and quantum sensing applications
New clinical practice guideline on the process for diagnosing Alzheimer’s disease or a related form of cognitive impairment or dementia
[Press-News.org] Dr. Knight Offers Interactive Where Does it Hurt Online ToolThe Hand and Wrist Institute, the leading hand specialist experts in the State of California now offers a "Where Does It Hurt" tool on their website, www.handandwristinstitute.com.